logo
Wolters Kluwer named Premier Leader in BPM Partners Vendor Landscape Matrix for third consecutive year for CCH Tagetik Intelligent Platform

Wolters Kluwer named Premier Leader in BPM Partners Vendor Landscape Matrix for third consecutive year for CCH Tagetik Intelligent Platform

Business Wire11-07-2025
NEW YORK--(BUSINESS WIRE)--Wolters Kluwer, a global leader in information, software, and services for professionals, today announced that its AI-powered CCH Tagetik Intelligent Platform has again been named Premier Leader in BPM Partners Vendor Landscape Matrix.
CCH Tagetik was further commended in the 2025 BPM Partners Vendor Landscape Matrix with a ranking of 'Outstanding' in Financial Consolidation and Customer Success and 'Excellent' in Financial Planning.
Karen Abramson, CEO of Wolters Kluwer Corporate Performance & ESG, said: 'We are honored that CCH Tagetik has been acknowledged as a Premier Leader for the third year running. We are committed to product excellence and innovation, and last year, we launched the market's first AI-powered corporate performance management platform—the CCH Tagetik Intelligent Platform with Ask AI —and we have now evolved Ask AI to an embedded super agent. We focus on anticipating emerging market trends and responding with solutions that support customers' current and future needs across business performance and transformation, and strategic risk management.'
The award-winning, AI-powered CCH® Tagetik Intelligent Platform digitally transforms the Office of the CFO's efficiency, accuracy, and strategic ability. It is a unified AI-powered platform for financial performance management (financial consolidation and close; budgeting, planning, and forecasting; ESG and regulatory reporting; corporate tax).
At the heart of its continuous evolution is Ask AI —an emerging super agent that embodies Agentic AI with a Finance Brain™. Designed to address finance-specific needs, Ask AI supports a growing range of use cases: from self-service analytics through natural language–driven data exploration and visualization, to tasks execution with diagnostic checks for financial close and consolidation, and intelligent assistance in configuring data transformation processes.
BPM Partners is the leading independent authority on business performance management (BPM/CPM/EPM) and related business intelligence solutions and has been recognized by Forbes as one of America's Best Management Consulting Firms. The company helps organizations address their budgeting, planning, financial consolidation, close and reporting, regulatory compliance, profitability optimization, key performance indicator (KPI) development, and operational performance challenges.
Craig Schiff, President and CEO at BPM Partners, said: 'Wolters Kluwer's high customer satisfaction scores, the comprehensive and innovative nature of its CCH Tagetik platform, and its commitment to continually investing in AI to drive the continued digital transformation of the Office of the CFO, all contribute to its third consecutive year as Premier Leader in our Vendor Landscape Matrix.'
Corporate Performance Management (CPM) business unit is part of the Wolters Kluwer Corporate Performance & ESG (CP & ESG) division. The division is the world's leading provider of integrated software solutions for EHS, ESG, Corporate Performance Management and Audit and Assurance. Through innovative technology and unique expertise, Wolters Kluwer CP & ESG enables business leaders to make informed, strategic decisions driving transformation, performance and risk management for a sustainable and resilient world.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies
GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies

Associated Press

time5 minutes ago

  • Associated Press

GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies

YONGIN, South Korea, Aug. 18, 2025 /PRNewswire/ -- GC Biopharma ( a South Korean biopharmaceutical company, announced today that it has signed a Memorandum of Understanding (MOU) with the Thai Red Cross Society (TRCS) to cooperate on workforce training for the production of plasma-derived medicinal products. This MOU formalizes and deepens a relationship that began in 2015, when GC Biopharma supported TRCS to establish a plasma fractionation facility in Thailand, and reflects the ongoing strategic collaboration between the two parties. Under the terms of the MOU, GC Biopharma and TRCS will jointly develop and operate on-site training and exchange programs for local production personnel. These programs aim to transfer GC Biopharma's advanced manufacturing technologies and expertise to support the development of local capabilities. In addition, both parties intend to continue identifying and expanding collaborative opportunities that align with their respective strengths and interests. The scope of cooperation will be gradually broadened to include potential joint projects such as the transfer of new processing technologies for plasma by-products and other strategic projects. 'This MOU is a significant step in broadening the reach of GC Biopharma's advanced technology and production standards across Asia,' said Hyoungjun Park, Vice President of GC Biopharma. 'Through our collaboration with the TRCS, we aim to achieve mutual growth while contributing to the public good.' 'Enhancing our personnel's capabilities through specialized training and direct knowledge transfer from GC Biopharma is essential to maintaining the quality, safety, and continuity of plasma-derived medicinal products production in Thailand,' said Assoc. Prof. Dootchai Chaiwanichsiri, Director of the National Blood Centre, TRCS. 'This collaboration not only supports the human resource development but also represents an important step for technology transfer and playing a vital role in strengthening the country's pharmaceutical and public health security.' Meanwhile, GC Biopharma continues to expand its global plasma-derived therapeutics business. In addition to entering the U.S. immunoglobulin market in 2024, the company is actively building partnerships in Southeast Asia, where domestic fractionation capabilities remain limited. About GC Biopharma GC Biopharma (formerly known as Green Cross Corporation) is a biopharmaceutical company headquartered in Yong-in, South Korea. The company has over half a century of experience in the development and manufacturing of plasma derivatives and vaccines, and is expanding its global presence with successful US market entry of Alyglo® (intravenous immunoglobulin G) in 2024. In line with its mission to meet the demands of future healthcare, GC Biopharma continues to drive innovation by leveraging its core R&D capabilities in engineering of proteins, mRNAs, and lipid nanoparticle (LNP) drug delivery platform to develop therapeutics for the field of rare disease as well as I&I (Immunology & Inflammation). To learn more about the company, visit This press release may contain biopharmaceuticals in forward-looking statements, which express the current beliefs and expectations of GC Biopharma's management. Such statements do not represent any guarantee by GC Biopharma or its management of future performance and involve known and unknown risks, uncertainties, and other factors. GC Biopharma undertakes no obligation to update or revise any forward-looking statement contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. GC Biopharma Contacts (Media) Sohee Kim [email protected] Yelin Jun [email protected] Yoonjae Na [email protected] View original content to download multimedia: SOURCE GC Biopharma

Mitsubishi Electric's Net Zero Energy Building Test Facility "SUSTIE" is Asian Regional Winner in ASHRAE Technology Awards Program
Mitsubishi Electric's Net Zero Energy Building Test Facility "SUSTIE" is Asian Regional Winner in ASHRAE Technology Awards Program

Yahoo

time2 hours ago

  • Yahoo

Mitsubishi Electric's Net Zero Energy Building Test Facility "SUSTIE" is Asian Regional Winner in ASHRAE Technology Awards Program

TOKYO, August 18, 2025--(BUSINESS WIRE)--Mitsubishi Electric Corporation, Mitsubishi Jisho Design Inc. and Waseda University jointly announced today that Mitsubishi Electric's Net Zero Energy Building Test Facility "SUSTIE," located in Kamakura, Kanagawa prefecture, was selected as Regional Winner (Regional Level Technology Awards 2025-2026 Regional Winner) in the Commercial Buildings (new) category of the ASHRAE® Technology Awards program. Organized by the Asian Region (ASHRAE Region XIII) of The American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE), the program is one of the world's biggest technology award initiatives focusing on environmentally friendly building design. ASHRAE Technology Awards, one of the world's biggest technology awards program for environmentally friendly buildingsThe ASHRAE Technology Awards program, held annually since 1999, is one of the world's biggest such programs, recognizing innovative environmentally-friendly buildings for their occupant comfort, indoor air quality and energy conservation, with evaluations based on the building's verifiable operating data. In the Asian region selection, SUSTIE was the Regional Winner in the New Commercial Buildings category at the ASHRAE Region XIII Chapters Regional Conference. This award will ensure SUSTIE is reviewed by ASHRAE as a representative project of the Asian region in the worldwide selection process. Mitsubishi Electric, Mitsubishi Jisho Design and Waseda University will continue in their efforts to realize "the World's Most Environmentally Friendly Building." ASHRAE: American Society of Heating, Refrigerating and Air-Conditioning Engineers (based in Atlanta, US) was established in 1894, and is the largest international body focusing on air conditioning. It has more than 50,000 members across more than 130 nations. For the full text, please visit: View source version on Contacts Mitsubishi Electric Corporation Public Relations DivisionE-mail: Mitsubishi Jisho Design Inc. Corporate Planning Department Public Relations OfficeTEL: +81-3-3287-5001 Waseda University Public Relation OfficeTEL: +81-3-3202-5454 Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Mitsubishi Electric's Net Zero Energy Building Test Facility 'SUSTIE' is Asian Regional Winner in ASHRAE Technology Awards Program
Mitsubishi Electric's Net Zero Energy Building Test Facility 'SUSTIE' is Asian Regional Winner in ASHRAE Technology Awards Program

Business Wire

time2 hours ago

  • Business Wire

Mitsubishi Electric's Net Zero Energy Building Test Facility 'SUSTIE' is Asian Regional Winner in ASHRAE Technology Awards Program

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation, Mitsubishi Jisho Design Inc. and Waseda University jointly announced today that Mitsubishi Electric's Net Zero Energy Building Test Facility 'SUSTIE,' located in Kamakura, Kanagawa prefecture, was selected as Regional Winner (Regional Level Technology Awards 2025-2026 Regional Winner) in the Commercial Buildings (new) category of the ASHRAE ® Technology Awards program. Organized by the Asian Region (ASHRAE Region XIII) of The American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE), the program is one of the world's biggest technology award initiatives focusing on environmentally friendly building design. ASHRAE Technology Awards, one of the world's biggest technology awards program for environmentally friendly buildings The ASHRAE Technology Awards program, held annually since 1999, is one of the world's biggest such programs, recognizing innovative environmentally-friendly buildings for their occupant comfort, indoor air quality and energy conservation, with evaluations based on the building's verifiable operating data. In the Asian region selection, SUSTIE was the Regional Winner in the New Commercial Buildings category at the ASHRAE Region XIII Chapters Regional Conference. This award will ensure SUSTIE is reviewed by ASHRAE as a representative project of the Asian region in the worldwide selection process. Mitsubishi Electric, Mitsubishi Jisho Design and Waseda University will continue in their efforts to realize 'the World's Most Environmentally Friendly Building.' ASHRAE: American Society of Heating, Refrigerating and Air-Conditioning Engineers (based in Atlanta, US) was established in 1894, and is the largest international body focusing on air conditioning. It has more than 50,000 members across more than 130 nations. For the full text, please visit:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store